Low-dose IL-2 therapy invigorates CD8(+) T cells for viral control in systemic lupus erythematosus

Autoimmune diseases are often treated by glucocorticoids and immunosuppressive drugs that could increase the risk for infection, which in turn deteriorate disease and cause mortality. Low-dose IL-2 (Ld-IL2) therapy emerges as a new treatment for a wide range of autoimmune diseases. To examine its in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Pengcheng, Chen, Jiali, He, Jing, Zheng, Ting, Yunis, Joseph, Makota, Victor, Alexandre, Yannick O., Gong, Fang, Zhang, Xia, Xie, Wuxiang, Li, Yuhui, Shao, Miao, Zhu, Yanshan, Sinclair, Jane E., Miao, Miao, Chen, Yaping, Short, Kirsty R., Mueller, Scott N., Sun, Xiaolin, Yu, Di, Li, Zhanguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525737/
https://www.ncbi.nlm.nih.gov/pubmed/34618873
http://dx.doi.org/10.1371/journal.ppat.1009858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525737/
https://www.ncbi.nlm.nih.gov/pubmed/34618873
http://dx.doi.org/10.1371/journal.ppat.1009858

Ejemplares similares